Please Wait.....
Report
Middle East and Africa Drug Delivery Devices Market
Market Report I 2024-08-01 I 217 Pages I Data Bridge Market Research
The Middle East and Africa drug delivery devices market is expected to reach USD 48.96 billion by 2031 from USD 26.41 billion in 2023, growing at a CAGR of 8.3% in the forecast period of 2024 to 2031.
Market Segmentation:
Middle East and Africa Drug Delivery Devices Market, By Product Type (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ophthalmic Drug Delivery, Nasal Drug Delivery, Pulmonary Drug Delivery, Transmucosal Drug Delivery, and Implantable Drug Delivery), End User (Hospitals, Home Healthcare, Clinics, Community Healthcare, and Others), Distribution Channel (Direct Tenders, Hospital Pharmacies, Pharmacy Stores, and Online Pharmacy), Country (South Africa, Egypt, Saudi Arabia, U.A.E., Israel, and rest of Middle East and Africa) - Industry Trends and Forecast to 2031
Overview of Middle East and Africa Drug Delivery Devices Market Dynamics:
Driver
- Rising prevalence of chronic disease and non-chronic disease
Restraint
- High costs of injectable drugs
Opportunity
- Rising acceptance of self-administering drug devices
Market Players:
The key market players operating in the Middle East and Africa drug delivery devices market are listed below:
- Johnson & Johnson Services, Inc.
- Novartis AG
- F.Hoffmann-La Roche Ltd
- Bayer AG
- Pfizer Inc.
- 3M
- AbbVie Inc.
- Amgen Inc.
- BD
- Elcam Medical
- Gerresheimer AG
- GSK plc.
- Insulet Corporation
- Merck & Co., Inc.
- Sanofi
- West Pharmaceutical Services Inc.
1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 24
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA DRUG DELIVERY DEVICES MARKET 24
1.4 CURRENCY AND PRICING 26
1.5 LIMITATIONS 26
1.6 MARKETS COVERED 26
2 MARKET SEGMENTATION 30
2.1 MARKETS COVERED 30
2.2 GEOGRAPHICAL SCOPE 31
2.3 YEARS CONSIDERED FOR THE STUDY 32
2.4 DBMR TRIPOD DATA VALIDATION MODEL 33
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 36
2.6 MULTIVARIATE MODELLING 37
2.7 MARKET END USER COVERAGE GRID 38
2.8 PRODUCT TYPE LIFELINE CURVE 38
2.9 DBMR MARKET POSITION GRID 39
2.10 VENDOR SHARE ANALYSIS 40
2.11 SECONDARY SOURCES 41
2.12 ASSUMPTIONS 41
3 EXECUTIVE SUMMARY 42
4 PREMIUM INSIGHTS 47
4.1 PORTERS FIVE FORCES 48
4.2 PESTEL ANALYSIS 49
5 REGULATORY FRAMEWORK 50
6 MARKET OVERVIEW 51
6.1 DRIVERS 53
6.1.1 RISING PREVALENCE OF CHRONIC DISEASE AND NON-CHRONIC DISEASE 53
6.1.2 GROWTH IN THE DEVELOPMENT OF BIOLOGICS DRUGS DEVICES 53
6.1.3 INCREASING AWARENESS ABOUT DIAGNOSIS AND TREATMENT 55
6.1.4 INCREASED FOCUS ON PERSONALIZED MEDICINE AND DEVICES 55
6.2 RESTRAINTS 56
6.2.1 RISK OF NEEDLE-STICK INJURIES AND SIDE EFFECTS 56
6.2.2 HIGH COSTS OF INJECTABLE DRUGS 57
6.2.3 STRINGENT REGULATORY SCENARIO 58
6.3 OPPORTUNITIES 59
6.3.1 RISING ACCEPTANCE OF SELF-ADMINISTERING DRUG DEVICES 59
6.3.2 RISING DEMAND FOR BIOSIMILAR AND GENERIC DRUGS 59
6.3.3 THERAPEUTIC ADVANCEMENTS IN THE FIELD OF DRUG DELIVERY 60
6.4 CHALLENGES 60
6.4.1 SIDE EFFECTS OF DRUG DELIVERY SYSTEMS 60
6.4.2 INCREASE IN THE NUMBER OF ALTERNATIVES OF DRUG DELIVERY 61
7 MIDDLE EAST AND AFRICA DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE 62
7.1 OVERVIEW 63
7.2 ORAL DRUG DELIVERY 66
7.2.1 SOLID ORAL DRUGS 67
7.2.1.1 TABLETS 67
7.2.1.2 CAPSULES 67
7.2.1.3 PILLS 67
7.2.1.4 POWDERS 67
7.2.2 LIQUID ORAL DRUGS 68
7.2.2.1 SYRUPS 68
7.2.2.2 SOLUTIONS 68
7.2.3 SEMI SOLID ORAL DRUGS 68
7.2.3.1 GELS 68
7.2.3.2 EMULSIONS 68
7.2.3.3 ELIXIRS 69
7.3 INJECTABLE DRUG DELIVERY 69
7.3.1 INJECTABLE DRUG DELIVERY FORMULATIONS 70
7.3.1.1 CONVENTIONAL DRUG DELIVERY FORMULATIONS 70
7.3.1.2 NOVEL DRUG DELIVERY FORMULATIONS 70
7.3.1.3 LONG ACTING INJECTION FORMULATIONS 70
7.3.2 INJECTABLE DRUG DELIVERY DEVICES 71
7.3.2.1 CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES 71
7.3.2.1.1 BY MATERIAL 71
7.3.2.1.1.1 GLASS 71
7.3.2.1.1.2 PLASTIC 72
7.3.2.1.2 BY PRODUCT TYPE 72
7.3.2.1.2.1 FILLABLE 72
7.3.2.1.2.2 PRE-FILLED 72
7.3.2.1.3 BY USABILITY 72
7.3.2.1.3.1 REUSABLE SYRINGES 72
7.3.2.1.3.2 DISPOSABLE SYRINGES 73
7.3.2.2 SELF INJECTION DRUG DELIVERY DEVICES 73
7.3.2.2.1 NEEDLE FREE INJECTORS 73
7.3.2.2.2 WEARABLE INJECTORS 73
7.3.2.2.3 PEN INJECTOR 73
7.3.2.2.4 AUTO INJECTORS 73
7.3.2.2.5 OTHERS 74
7.4 TOPICAL DRUG DELIVERY 75
7.4.1 TRANSDERMAL DRUG DELIVERY FORMULATIONS 75
7.4.1.1 SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS 76
7.4.1.1.1 OINTMENTS 76
7.4.1.1.2 CREAMS 76
7.4.1.1.3 LOTIONS 76
7.4.1.1.4 GELS 76
7.4.1.1.5 PASTES 76
7.4.1.2 LIQUID TOPICAL DRUG DELIVERY FORMULATIONS 77
7.4.1.2.1 SUSPENSIONS 77
7.4.1.2.2 SOLUTIONS 77
7.4.1.3 SOLID TOPICAL DRUG DELIVERY FORMULATIONS 77
7.4.1.3.1 POWDER 77
7.4.1.3.2 SUPPOSITORS 78
7.5 OPHTHALMIC DRUG DELIVERY 78
7.5.1 OCCULAR DRUG DELIVERY FORMULATIONS 79
7.5.1.1 LIQUID OCCULAR DRUG DELIVERY FORMULATIONS 79
7.5.1.1.1 SOLUTIONS 79
7.5.1.1.2 SUSPENSIONS 79
7.5.1.2 SEMI SOLID OCCULAR DRUG DELIVERY FORMULATIONS 80
7.5.1.2.1 GELS 80
7.5.1.2.2 OINTMENTS 80
7.5.2 OCCULAR DRUG DELIVERY DEVICES 80
7.6 NASAL DRUG DELIVERY 80
7.6.1 NASAL DROPS 81
7.6.2 NASAL SPRAYS 81
7.6.3 NASAL POWDERS 81
7.6.4 NASAL GELS 81
7.7 PULMONARY DRUG DELIVERY 81
7.7.1 METERED DOSE INHALERS (MDI) 82
7.7.2 DRY POWDER INHALERS (DPI) 82
7.7.3 NEBULIZERS 82
7.7.3.1 JET NEBULIZERS 82
7.7.3.2 ULTRASONIC NEBULIZERS 83
7.7.3.3 SOFT MIST NEBULIZERS 83
7.8 TRANSMUCOSAL DRUG DELIVERY 83
7.8.1 ORAL TRANSMUCOSAL DRUG DELIVERY 84
7.8.1.1 BUCCAL DRUG DELIVERY 84
7.8.1.2 SUBLINGUAL DRUG DELIVERY 84
7.8.2 OTHER TRANSMUCOSAL DRUG DELIVERY 84
7.8.2.1 RECTAL TRANSMUCOSAL DRUG DELIVERY 84
7.8.2.2 VAGINAL TRANSMUCOSAL DRUG DELIVERY 85
7.9 IMPLANTABLE DRUG DELIVERY 85
7.9.1 PASSIVE IMPLANTABLE DRUG DELIVERY DEVICES 85
7.9.2 ACTIVE IMPLANTABLE DRUG DELIVERY DEVICES 85
8 MIDDLE EAST AND AFRICA DRUG DELIVERY DEVICES MARKET, BY END USER 86
8.1 OVERVIEW 87
8.2 HOSPITALS 90
8.3 HOME HEALTHCARE 90
8.4 CLINICS 91
8.5 COMMUNITY HEALTHCARE 91
8.6 OTHERS 92
9 MIDDLE EAST AND AFRICA DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 93
9.1 OVERVIEW 94
9.2 DIRECT TENDERS 97
9.3 HOSPITAL PHARMACIES 97
9.4 PHARMACY STORES 98
9.5 ONLINE PHARMACY 98
10 MIDDLE EAST AND AFRICA DRUG DELIVERY DEVICES MARKET, BY REGION 99
10.1 MIDDLE EAST AND AFRICA 101
10.1.1 SOUTH AFRICA 109
10.1.2 SAUDI ARABIA 117
10.1.3 U.A.E. 125
10.1.4 EGYPT 133
10.1.5 ISRAEL 141
10.1.6 REST OF MIDDLE EAST AND AFRICA 149
11 MIDDLE EAST AND AFRICA DRUG DELIVERY DEVICES MARKET: COMPANY LANDSCAPE 150
11.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
12 SWOT ANALYSIS 151
13 COMPANY PROFILE 152
13.1 JOHNSON & JOHNSON SERVICES, INC. 152
13.1.1 COMPANY SNAPSHOT 152
13.1.2 REVENUE ANALYSIS 152
13.1.3 COMPANY SHARE ANALYSIS 153
13.1.4 PRODUCT PORTFOLIO 153
13.1.5 RECENT DEVELOPMENTS 155
13.2 NOVARTIS AG 157
13.2.1 COMPANY SNAPSHOT 157
13.2.2 REVENUE ANALYSIS 157
13.2.3 COMPANY SHARE ANALYSIS 158
13.2.4 PRODUCT PORTFOLIO 158
13.2.5 RECENT DEVELOPMENTS 158
13.3 F. HOFFMANN-LA ROCHE LTD 160
13.3.1 COMPANY SNAPSHOT 160
13.3.2 REVENUE ANALYSIS 160
13.3.3 COMPANY SHARE ANALYSIS 161
13.3.4 PRODUCT PORTFOLIO 161
13.3.5 RECENT DEVELOPMENT 161
13.4 BAYER AG 162
13.4.1 COMPANY SNAPSHOT 162
13.4.2 REVENUE ANALYSIS 162
13.4.3 COMPANY SHARE ANALYSIS 163
13.4.4 PRODUCT PORTFOLIO 163
13.5 PFIZER INC. 164
13.5.1 COMPANY SNAPSHOT 164
13.5.2 REVENUE ANALYSIS 164
13.5.3 COMPANY SHARE ANALYSIS 165
13.5.4 PRODUCT PORTFOLIO 165
13.5.5 RECENT DEVELOPMENT 165
13.6 3M 166
13.6.1 COMPANY SNAPSHOT 166
13.6.2 REVENUE ANALYSIS 166
13.6.3 PRODUCT PORTFOLIO 167
13.6.4 RECENT DEVELOPMENTS 167
13.7 ABBVIE INC. 168
13.7.1 COMPANY SNAPSHOT 168
13.7.2 REVENUE ANALYSIS 169
13.7.3 PRODUCT PORTFOLIO 169
13.7.4 RECENT DEVELOPMENTS 170
13.8 AMGEN INC. 171
13.8.1 COMPANY SNAPSHOT 171
13.8.2 REVENUE ANALYSIS 171
13.8.3 PRODUCT PORTFOLIO 172
13.8.4 RECENT DEVELOPMENTS 173
13.9 BD 174
13.9.1 COMPANY SNAPSHOT 174
13.9.2 REVENUE ANALYSIS 174
13.9.3 PRODUCT PORTFOLIO 175
13.9.4 RECENT DEVELOPMENT 178
13.10 ELCAM MEDICAL 179
13.10.1 COMPANY SNAPSHOT 179
13.10.2 PRODUCT PORTFOLIO 179
13.10.3 RECENT DEVELOPMENT 180
13.11 ENABLE INJECTIONS 181
13.11.1 COMPANY SNAPSHOT 181
13.11.2 PRODUCT PORTFOLIO 181
13.11.3 RECENT DEVELOPMENTS 182
13.12 GERRESHEIMER AG 184
13.12.1 COMPANY SNAPSHOT 184
13.12.2 REVENUE ANALYSIS 184
13.12.3 PRODUCT PORTFOLIO 185
13.12.4 RECENT DEVELOPMENTS 188
13.13 GSK PLC. 190
13.13.1 COMPANY SNAPSHOT 190
13.13.2 REVENUE ANALYSIS 190
13.13.3 PRODUCT PORTFOLIO 191
13.13.4 RECENT DEVELOPMENTS 193
13.14 INSULET CORPORATION 195
13.14.1 COMPANY SNAPSHOT 195
13.14.2 REVENUE ANALYSIS 195
13.14.3 PRODUCT PORTFOLIO 196
13.14.4 RECENT DEVELOPMENTS 196
13.15 MEDMIX 197
13.15.1 COMPANY SNAPSHOT 197
13.15.2 REVENUE ANALYSIS 197
13.15.3 PRODUCT PORTFOLIO 198
13.15.4 RECENT DEVELOPMENTS 199
13.16 MERCK & CO., INC. 201
13.16.1 COMPANY SNAPSHOT 201
13.16.2 REVENUE ANALYSIS 201
13.16.3 PRODUCT PORTFOLIO 202
13.16.4 RECENT DEVELOPMENT 202
13.17 ORASURE TECHNOLOGIES INC. 203
13.17.1 COMPANY SNAPSHOT 203
13.17.2 REVENUE ANALYSIS 203
13.17.3 PRODUCT PORTFOLIO 204
13.17.4 RECENT DEVELOPMENT 204
13.18 SANOFI 205
13.18.1 COMPANY SNAPSHOT 205
13.18.2 REVENUE ANALYSIS 205
13.18.3 PRODUCT PORTFOLIO 206
13.18.4 RECENT DEVELOPMENTS 208
13.19 SMC LTD. 209
13.19.1 COMPANY SNAPSHOT 209
13.19.2 REVENUE ANALYSIS 209
13.19.3 PRODUCT PORTFOLIO 210
13.19.4 RECENT DEVELOPMENTS 210
13.20 VIVO SMART MEDICAL DEVICES LTD. 211
13.20.1 COMPANY SNAPSHOT 211
13.20.2 PRODUCT PORTFOLIO 211
13.20.3 RECENT DEVELOPMENT 211
13.21 WEST PHARMACEUTICAL SERVICES, INC. 212
13.21.1 COMPANY SNAPSHOT 212
13.21.2 REVENUE ANALYSIS 212
13.21.3 PRODUCT PORTFOLIO 213
13.21.4 RECENT DEVELOPMENT 213
14 QUESTIONNAIRE 214
15 RELATED REPORTS 217
13.21.4 RECENT DEVELOPMENT 213
14 QUESTIONNAIRE 214
15 RELATED REPORTS 217
?
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security